在使用外部评估的人口药理动力学模型的成年患者中优化泰科普拉宁剂量方案
Xiaojing Li1, Qiang Sun, Genzhu Wang
1Department of Pharmacy, Beijing Electric Power Hospital of State Grid Co. of China, Capital Medical University Electric Teaching Hospital, Beijing, China.
这项研究确定了Ogami等人. 人口的药动力学模型是个性化提科普拉宁 (抗生素) 剂量在中国成年人中最佳的. 这种模型指导了针对各种感染的精确泰克奥普拉宁 (抗生素) 剂量.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 制药指标 (Pharmacometrics) 是一个指标.
背景情况:
- 优化teicoplanin剂量对于成年中国患者的有效治疗至关重要.
- 种群药动力学 (PopPK) 模型对于实现个性化泰可普拉宁治疗至关重要.
研究的目的:
- 确定最适合在中国成年患者中使用提科普拉宁剂量的群体药动力学模型.
- 通过外部验证和模拟来评估现有的 teicoplanin PopPK 模型.
主要方法:
- 在PubMed和Web of Science中对teicoplanin PopPK模型进行系统的文献搜索.
- 用北京电力医院的患者数据对已识别的模型进行外部评估.
- 应用非线性混合效应建模 (NLME) 和蒙特卡洛模拟用于模型评估.
主要成果:
- 奥加米人和其他人. 该模型显示出出色的预测性能 (偏差 -7.56%,不准确率为26.28%).
- 经过验证的模型提供了空隙和体积的特定参数.
- 蒙特卡洛模拟表明,根据感染严重程度,加载剂量为400-800毫克,维护剂量为400-600毫克.
结论:
- 奥加米人和其他人. 人口药动力学模型非常适合在中国成年患者中指导提科普拉宁剂量.
- 结合外部评估和模拟证实了该模型在不同临床场景中的实用性.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
06:19Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections
Published on: October 11, 2024
相关概念视频
Analysis of Population Pharmacokinetic Data
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Three-Compartment Open Model
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
